At the early stage (day 4), the tumour fluorescent intensity of the CD19‐positive group (1.19 ± 0.20) was significantly lower than that of the CD19‐negative group (3.28 ± 1.03) with P = .011. This evidence concerns the gene CD19 and neoplasm.